CNR1 and arthritic joint disease: Intraperitoneal administration of Δ9-THC or anandamide:- anti-nociceptive effect of Δ9-THC and anandamide- SR141716A (CB1 inhibitor) blocked THC, but not anandamide-induced nociception- no potential contribution of endogenous anandamide in arthritis